Pfizer and Mylan to Sell Assets, Gain Clearance for Deal

(Bloomberg) -- The U.S. Federal Trade Commission said Pfizer Inc. and Mylan NV agreed to sell some assets to gain approval for a deal combining Pfizer’s off-patent unit with the generic-drug maker.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.